Healthcare and Life Science
Unlocking seamless connectivity: In-building wireless solutions are the future
In today’s fast-paced digital world, connectivity is no longer a luxury - it’s a necessity. From corporate offices to hospitals, sprawling warehouses and everything in between, the demand for reliable, high-performance wireless coverage has never been greater. Yet it remains a challenge...
Finding Clarity, Support and Momentum as an Innovation Entrepreneur
By Garry Jennings, Innovation Director, The EpiCentre
Sapio Sciences makes AI-native drug discovery seamless with NVIDIA BioNeMo
Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle ...
25 years of working in Mental Health
Claire Harris, Health Psychologist and Founder of Promote Mental Health celebrates working in the mental health field for 25 years. Read this blog for her views on what has changed over the last 25 years, and what she hopes for the future in the mental health sector. ...
More on private 5G
Bruce Lancaster, CEO, Wilson Connectivity, on the positioning of private 5G as a reliable option for secure, high-capacity and low-latency communication needs.Private 5G networks have entered a steady growth phase, transitioning from a long-standing concept to a tangible solution addres...
WaveFX reach finals of SME National Business Awards for Best Enterprising Business
WaveFX, a leading event filming and webcasting company, is thrilled to announce that it has been named a finalist in the prestigious SME National Business Awards. The company is competing in the highly sought-after Best Enterprising Business category, recognizing its innovation, resilie...
Cambridge scientist launches free VR platform that eliminates the fear of public speaking
Dr Chris Macdonald creates free virtual reality platform that transforms users into skilled and confident public speakers ...
Living with Pulmonary Arterial Hypertension: Early Diagnosis, Patient Advocacy, and the Role of Technology
Co-authored by Maleen Fischer, PHA Europe
SolasCure enrols first patient in a next Phase II clinical trial to advance Aurase Wound Gel
Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcersCambridge, UK 17 March 2025: SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic w...